<?xml version="1.0" encoding="UTF-8"?>
<ref id="B120-ijerph-17-05904">
 <label>120.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Cattaneo</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Bertinato</surname>
    <given-names>E.M.</given-names>
   </name>
   <name>
    <surname>Birocchi</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Brizio</surname>
    <given-names>C.</given-names>
   </name>
   <name>
    <surname>Malavolta</surname>
    <given-names>D.</given-names>
   </name>
   <name>
    <surname>Manzoni</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Muscarella</surname>
    <given-names>G.</given-names>
   </name>
   <name>
    <surname>Orlandi</surname>
    <given-names>M.</given-names>
   </name>
  </person-group>
  <article-title>Pulmonary embolism or pulmonary thrombosis in COVID-19? Is the recommendation to use high-dose heparin for thromboprophylaxis justified?</article-title>
  <source>Thromb. Haemost.</source>
  <year>2020</year>
  <pub-id pub-id-type="doi">10.1055/s-0040-1712097</pub-id>
 </element-citation>
</ref>
